|
Market Closed -
NYSE
04:00:02 2026-09-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 161.63 USD | -0.52% |
|
-4.24% | +75.82% |
| Sep. 02 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| Sep. 02 | AstraZeneca PLC : Deutsche Bank reiterates its Sell rating | ZD |
| Market Cap | 251B 217B 204B 186B 347B 23,822B 350B 2,414B 936B 12,118B 942B 921B 39,832B | P/E 2026 * |
20.8x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 270B 233B 220B 200B 374B 25,657B 377B 2,600B 1,009B 13,051B 1,015B 992B 42,901B | EV / Sales 2026 * |
4.27x | EV / Sales 2027 * | 3.93x |
| Free-Float |
96.63% | Yield 2026 * |
2.06% | Yield 2027 * | 2.2% |
Last Transcript : AstraZeneca PLC
| 1 day | -0.52% | ||
| Current month | +74.23% | ||
| Current year | +75.82% |
| Current year | 89.04 |  | 164.69 |
| 1 year | 72.9 | | 164.69 |
| 3 years | 60.47 | | 164.69 |
| 5 years | 52.65 | | 164.69 |
| 10 years | 25.55 | | 164.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -4.24% | - | - | 251B | |
| +0.01% | -5.96% | +58.36% | +108.23% | 1,034B | |
| +1.48% | +0.76% | +55.34% | +71.49% | 654B | |
| +0.67% | -1.53% | +24.39% | +76.60% | 459B | |
| +0.49% | -6.58% | +34.20% | +34.59% | 343B | |
| +0.27% | +2.32% | +29.33% | +46.97% | 307B | |
| +0.12% | -4.01% | +1.06% | +11.93% | 251B | |
| +1.08% | +0.14% | +53.92% | +72.51% | 237B | |
| +2.64% | -2.00% | -17.38% | -53.64% | 202B | |
| -0.21% | +0.56% | +32.43% | +95.19% | 186B | |
| Average | +0.59% | -2.88% | +30.18% | +51.54% | 407.95B | |
| Weighted average by Cap. | +0.58% | -3.31% | +39.22% | +67.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.24B 54.58B 51.41B 46.91B 87.56B 6,005B 88.22B 608B 236B 3,055B 237B 232B 10,041B | 66.82B 57.68B 54.32B 49.56B 92.52B 6,345B 93.21B 643B 249B 3,228B 251B 245B 10,610B |
| Net income | 12.02B 10.38B 9.77B 8.92B 16.65B 1,142B 16.77B 116B 44.88B 581B 45.14B 44.16B 1,909B | 13.61B 11.75B 11.07B 10.1B 18.84B 1,292B 18.99B 131B 50.8B 657B 51.11B 49.99B 2,161B |
| Net Debt | 19.33B 16.68B 15.71B 14.34B 26.76B 1,835B 26.96B 186B 72.14B 934B 72.57B 70.98B 3,069B | 11.65B 10.06B 9.47B 8.64B 16.13B 1,106B 16.26B 112B 43.49B 563B 43.75B 42.8B 1,850B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | $161.63 | -0.52% | 3,300,561 |
| 26-09-01 | $162.47 | +0.21% | 2,598,488 |
| 26-08-31 | $162.13 | -0.35% | 3,068,214 |
| 26-08-28 | $162.70 | -1.11% | 2,880,829 |
| 26-08-27 | $164.52 | -1.05% | 2,495,242 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
